mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
2e-05 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-05 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-05 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
5e-05 |